{"data":{"id":"us-in/ic-27-8-30-3","jurisdiction":"us-in","citation":"IC 27-8-30-3","heading":"Allowing an insurer to report the number of covered children who are prescribed a stimulant medication for the treatment of certain disorders","body":"Sec. 3. An insurer that issues an accident and sickness insurance policy may report to the drug utilization review board established by IC 12-15-35-19 the number of covered individuals who are:\n(1) less than eighteen (18) years of age; and\n(2) prescribed a stimulant medication approved by the federal Food and Drug Administration for the treatment of attention deficit disorder or attention deficit hyperactivity disorder.","path":["TITLE 27. INSURANCE","ARTICLE 8. LIFE, ACCIDENT, AND HEALTH","Chapter 30. Specific Accident and Sickness Insurance Reporting Requirements"],"source_url":"https://iga.in.gov/ic/2026/Title_27.html#27-8-30-3","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-25T05:39:04Z","sha256":"1ebc6641ec790f3319b4e435d180b0159cc635c210b52100a147c6bdba7998d6","source_id":"us-in","stale":false,"prev":"us-in/ic-27-8-30-2","next":"us-in/ic-27-8-31-1"},"notice":"GroundRules: Original legal text. Not legal advice."}